MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumoursAndrew R. Green, Emad A. Rakha, Mohammed A. Aleskandarany et al.|British Journal of Cancer|2016Cited by 140
Biological and clinical significance of PARP1 protein expression in breast cancerAndrew R. Green, Emad A. Rakha, Srinivasan Madhusudan et al.|Breast Cancer Research and Treatment|2014Cited by 85
KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancerAlaa T. Alshareeda, Emad A. Rakha, Ola H. Negm et al.|British Journal of Cancer|2015Cited by 76
Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancerAlaa T. Alshareeda, Emad A. Rakha, Ola H. Negm et al.|Breast Cancer Research and Treatment|2013Cited by 62
Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy responseMethaq Mueen Al-kaabi, Emad A. Rakha, Alaa T. Alshareeda et al.|British Journal of Cancer|2015Cited by 50